Crossmark

Pharmacokinetics, bioequivalence, and food effect assessment of enteric-coated aspirin tablets: a randomized, single-dose, four-period crossover study in Chinese healthy subjects

Crossref DOI link: https://doi.org/10.1007/s00210-025-04282-w

Published Online: 2025-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Minwan

Zhang, Shuyu

Xu, Peng

Li, Jiangfan

Pang, Hongxian

Yang, Man

Chen, Fangyu

Gao, Baoqing

Wang, Xuhong
License Information

Text and Data Mining valid from 2025-05-23

Version of Record valid from 2025-05-23
More Information

Article History

Received: 26 March 2025

Accepted: 8 May 2025

First Online: 23 May 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of Beijing Luhe Hospital (Ethics Approval Number: 2022-LHYW-055–01). Consent to participate and informed consent were obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below